CN Stock MarketDetailed Quotes
002773 Chengdu Kanghong Pharmaceutical Group
- 18.62
- -0.16-0.85%
Market Closed Jan 9 15:00 CST
17.13BMarket Cap14.36P/E (TTM)
18.85High18.53Low32.41KlotVolume18.65Open18.78Pre Close60.57MTurnover0.47%Turnover Ratio16.39P/E (Static)919.78MShares24.5052wk High2.03P/B12.76BFloat Cap12.7752wk Low20.66Limit Up685.34MShs Float52.71Historical High16.90Limit Down1.70%Amplitude6.72Historical Low0.38Dividend TTM18.69Avg Price18.28KlotAsk2.04%Div YieldTTM100Lot Size13.48KlotBid
Chengdu Kanghong Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 13.75%3.41B | 19.46%2.29B | 23.50%1.09B | 16.77%3.96B | 13.96%3B | 8.90%1.92B | -1.16%884.84M | -6.00%3.39B | -7.49%2.63B | -7.18%1.76B |
| Operating revenue | 13.75%3.41B | 19.46%2.29B | 23.50%1.09B | 16.77%3.96B | 13.96%3B | 8.90%1.92B | -1.16%884.84M | -6.00%3.39B | -7.49%2.63B | -7.18%1.76B |
| Other operating revenue | ---- | 515.65%797.2K | ---- | -1.40%626.85K | ---- | -63.51%129.49K | ---- | 240.28%635.74K | ---- | 546.65%354.86K |
| Total operating cost | 11.92%2.31B | 13.23%1.51B | 16.71%658.81M | 13.38%2.81B | 12.67%2.07B | 12.21%1.34B | -0.18%564.5M | -21.79%2.48B | -18.80%1.83B | -21.35%1.19B |
| Operating cost | 5.78%345.31M | 8.92%234.07M | 10.50%114.86M | 12.98%438.41M | 12.74%326.43M | 9.12%214.89M | 5.89%103.94M | 9.43%388.04M | 5.46%289.55M | 8.93%196.93M |
| Operating tax surcharges | 11.52%42.57M | 8.60%30.93M | 37.69%13.2M | 15.70%56.08M | 12.11%38.17M | 9.01%28.48M | -14.68%9.59M | -5.10%48.47M | -8.69%34.05M | -4.31%26.13M |
| Operating expense | 9.53%1.29B | 15.70%857.73M | 28.76%387.76M | 11.41%1.47B | 12.12%1.18B | 9.25%741.34M | -7.83%301.16M | -5.94%1.32B | -7.23%1.05B | -5.08%678.55M |
| Administration expense | 11.10%340.31M | 10.73%228.63M | 2.61%95.45M | 21.09%472.38M | 19.56%306.3M | 20.01%206.48M | 13.40%93.03M | 2.05%390.11M | -0.89%256.19M | 7.05%172.06M |
| Financial expense | -17.65%-46.38M | -24.55%-32.06M | -37.26%-16.3M | -16.49%-52.35M | -32.20%-39.42M | -65.17%-25.74M | -61.27%-11.87M | -30.92%-44.94M | -19.29%-29.82M | -1.64%-15.58M |
| -Interest Income (Financial expense) | -17.21%-47.01M | -21.84%-31.19M | -30.08%-15.42M | -16.47%-52.5M | -32.96%-40.1M | -62.71%-25.6M | -55.27%-11.85M | -28.33%-45.08M | -21.52%-30.16M | -2.94%-15.73M |
| Research and development | 32.44%342.16M | 13.39%192.87M | -7.02%63.85M | 12.75%421.68M | 10.08%258.35M | 28.69%170.1M | 25.46%68.66M | -62.91%374M | -59.67%234.69M | -70.30%132.18M |
| Credit Impairment Loss | -90.50%-1.98M | -49.56%-2.75M | 77.61%-356.21K | -687.10%-1.32M | -159.84%-1.04M | -118.49%-1.84M | -153.25%-1.59M | -91.88%224.36K | -186.85%-400.66K | -199.86%-843.05K |
| Asset Impairment Loss | -689.85%-746.32K | -175.87%-746.32K | ---- | 94.41%-230.53K | 113.11%126.53K | 201.89%983.62K | ---- | 98.09%-4.13M | -87.66%-965.35K | -87.66%-965.35K |
| Other net revenue | -20.78%49.2M | -15.58%38.58M | -19.72%12.57M | 8.25%110.68M | -13.04%62.1M | -4.76%45.7M | -29.37%15.65M | 220.91%102.24M | -5.14%71.41M | -6.04%47.98M |
| Fair value change income | -535.16%-1.39M | ---969.6K | --268.8K | ---832.8K | ---218.4K | ---- | ---- | ---- | ---- | ---- |
| Invest income | -6.98%20.32M | 7.38%19.27M | -103.46%-53.16K | 18.31%45.03M | 12.56%21.84M | 33.30%17.94M | -39.37%1.54M | 44.04%38.06M | 24.60%19.4M | 16.38%13.46M |
| -Including: Investment income associates | 20.95%-200.11K | 52.09%-106.49K | 53.56%-53.16K | 72.29%-207.24K | 40.48%-253.16K | 7.74%-222.24K | 24.58%-114.47K | -20.69%-747.78K | -8.43%-425.3K | 14.07%-240.88K |
| Asset deal income | 128.39%14.59K | --13.97K | ---- | --9.03K | ---51.39K | ---- | ---- | ---- | ---- | ---- |
| Other revenue | -20.41%32.98M | -16.94%23.77M | -19.11%12.71M | -0.09%68.02M | -22.35%41.44M | -21.23%28.62M | -22.45%15.71M | -33.44%68.08M | -10.69%53.37M | -7.26%36.33M |
| Operating profit | 15.41%1.15B | 30.13%820.53M | 32.90%446.54M | 24.20%1.26B | 14.45%995.37M | 1.52%630.55M | -4.51%335.99M | 185.88%1.02B | 31.30%869.67M | 41.95%621.11M |
| Add:Non operating Income | -54.52%2.34M | -79.36%1.01M | -80.73%249.11K | -94.81%1.37M | -60.55%5.15M | -49.24%4.91M | 125.44%1.29M | -53.46%26.45M | -54.85%13.04M | 73.18%9.68M |
| Less:Non operating expense | -29.61%12.89M | -70.50%4.25M | -67.06%805.68K | 147.58%28.52M | 133.25%18.31M | 298.60%14.39M | 133.08%2.45M | -38.00%11.52M | -17.10%7.85M | -41.35%3.61M |
| Total profit | 15.88%1.14B | 31.59%817.3M | 33.19%445.98M | 19.76%1.23B | 12.27%982.2M | -0.97%621.08M | -4.71%334.84M | 161.88%1.03B | 28.33%874.86M | 43.52%627.18M |
| Less:Income tax cost | 4.39%173.28M | 29.00%130.76M | 29.25%74.51M | 23.29%202.79M | 32.90%165.99M | 8.66%101.37M | 5.04%57.64M | 694.66%164.49M | 336.53%124.9M | 465.35%93.29M |
| Net profit | 18.22%964.89M | 32.10%686.54M | 34.01%371.48M | 19.09%1.03B | 8.83%816.21M | -2.66%519.71M | -6.51%277.2M | 105.62%865.81M | 14.82%749.96M | 26.97%533.9M |
| Net profit from continuing operation | 18.22%964.89M | 32.10%686.54M | 34.01%371.48M | 19.09%1.03B | 8.83%816.21M | -2.66%519.71M | -6.51%277.2M | 105.62%865.81M | 14.82%749.96M | 26.97%533.9M |
| Less:Minority Profit | 3.63%-8.82M | -0.92%-5.68M | 4.17%-2.05M | 55.79%-13.64M | -93.18%-9.15M | -76.44%-5.63M | -187.20%-2.14M | -809,682.39%-30.86M | ---4.74M | ---3.19M |
| Net profit of parent company owners | 17.97%973.71M | 31.77%692.22M | 33.72%373.52M | 16.52%1.04B | 9.36%825.36M | -2.19%525.34M | -6.03%279.33M | 112.94%896.67M | 15.55%754.7M | 27.73%537.09M |
| Earning per share | ||||||||||
| Basic earning per share | 17.78%1.06 | 31.58%0.75 | 36.67%0.41 | 16.33%1.14 | 9.76%0.9 | -1.72%0.57 | -6.25%0.3 | 113.04%0.98 | 15.49%0.82 | 26.09%0.58 |
| Diluted earning per share | 17.78%1.06 | 31.58%0.75 | 36.67%0.41 | 16.33%1.14 | 9.76%0.9 | -1.72%0.57 | -6.25%0.3 | 113.04%0.98 | 15.49%0.82 | 26.09%0.58 |
| Other composite income | 27.80%-148.09K | -892.21%-470.34K | -90.40%-586.68K | -32.29%-291.3K | -207.67%-205.1K | 86.24%-47.4K | -40.49%-308.13K | 48.50%-220.2K | 146.19%190.5K | -25.98%-344.41K |
| Other composite income of parent company owners | 27.80%-148.09K | -892.21%-470.34K | -90.40%-586.68K | -32.29%-291.3K | -207.67%-205.1K | 86.24%-47.4K | -40.49%-308.13K | 48.50%-220.2K | 146.19%190.5K | -25.98%-344.41K |
| Total composite income | 18.23%964.74M | 32.02%686.07M | 33.95%370.89M | 19.09%1.03B | 8.78%816M | -2.60%519.66M | -6.54%276.89M | 105.77%865.59M | 14.93%750.15M | 26.97%533.55M |
| Total composite income of parent company owners | 17.99%973.56M | 31.69%691.75M | 33.66%372.93M | 16.51%1.04B | 9.31%825.16M | -2.13%525.29M | -6.06%279.02M | 113.11%896.45M | 15.65%754.89M | 27.73%536.74M |
| Total composite income of minority owners | 3.63%-8.82M | -0.92%-5.68M | 4.17%-2.05M | 55.79%-13.64M | -93.18%-9.15M | -76.44%-5.63M | -187.20%-2.14M | -809,682.39%-30.86M | ---4.74M | ---3.19M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
